Life after the WHI: evaluation of postmenopausal symptoms and use of alternative therapies after discontinuation of hormone

被引：0
|
作者：
Shrader, SP [1 ]
Ragucci, KR [1 ]
机构：
[1] Med Univ S Carolina, Charleston, SC USA
来源：
PHARMACOTHERAPY | 2005年 / 25卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1493 / 1493
页数：1
相关论文
共 50 条
  • [1] Life after the women's health initiative: Evaluation of postmenopausal symptoms and use of alternative therapies after discontinuation of hormone therapy
    Shrader, Sarah P.
    Ragucci, Kelly R.
    PHARMACOTHERAPY, 2006, 26 (10): : 1403 - 1409
  • [2] Prevention of postmenopausal bone loss after WHI
    Watts, NB
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 560 - 560
  • [3] Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial
    Biglia, Nicoletta
    Ujcic, Ester
    Kubatzki, Franziska
    Sgandurra, Paola
    Robba, Claudio
    Ponzone, Riccardo
    Sismondi, Piero
    MATURITAS, 2006, 54 (02) : 181 - 192
  • [4] Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication
    Guay, Marie-Pascale
    Dragomir, Alice
    Pilon, Danielle
    Moride, Yola
    Perreault, Sylvie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (01) : 17 - 27
  • [5] Hormone therapy use among inner city women after the WHI.
    Helenius, IM
    Korenstein, D
    Halm, EA
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 158 - 159
  • [6] Alendronate use in postmenopausal women with low bone mass combination with comparison to and use after discontinuation of hormone replacement therapy.
    Harris, ST
    Bone, HG
    Ascott-Evans, BH
    Melton, ME
    Lombardi, A
    Stych, B
    Freedholm, DA
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S291 - S291
  • [7] Potential implications for the prevention of postmenopausal osteoporosis after premature discontinuation of the estrogen and progestin arm of the womens health initiative (WHI)
    Dören, M
    Scheidt-Nave, C
    Baum, E
    Minne, H
    Pfeilschifter, J
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S18 - S19
  • [8] Postmenopausal hormone use and mortality after breast cancer
    Newcomb, P. A.
    Egan, K. M.
    Trentham, Dietz A.
    Titus, Ernstoff L.
    Baron, J. A.
    Hampton, J. M.
    Wong, E. Y.
    Stampfer, M. J.
    Willett, W. C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) : 361 - 361
  • [9] Alendronate use in postmenopausal women with low bone mass: Combination with, comparison to, and use after discontinuation of hormone replacement therapy (HRT).
    Harris, ST
    Bone, HG
    Ascott-Evans, BH
    Melton, ME
    Lombardi, A
    Stych, B
    Freedholm, DA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S526 - S526
  • [10] Bone Density Declines In Postmenopausal Women Discontinuing Hormone Therapy After Publication Of 2002 WHI Report
    Lohman, Timothy
    Cussler, Ellen
    Going, Scott
    Blew, Robert
    Houtkooper, Linda
    Metcalfe, Lauve
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2005, 37 : S460 - S461
12345